carbamates has been researched along with dc 88-a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boger, DL; Duncan, KK; Parelkar, NK; Vielhauer, GA; Weir, SJ; Wolfe, AL | 1 |
1 other study(ies) available for carbamates and dc 88-a
Article | Year |
---|---|
A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Line, Tumor; Cyclopropanes; Drug Design; Duocarmycins; Humans; Hydrolysis; Indoles; Inhibitory Concentration 50; Mice; Prodrugs; Pyrrolidinones; Xenograft Model Antitumor Assays | 2012 |